β¨ Medicines and Education Notices
NEW ZEALAND GAZETTE, No. 90 β 20 AUGUST 2015
Product:
Viekira Pak-RBV
Component 1:
Active Ingredients:
- Ombitasvir 12.5mg
- Paritaprevir 75mg
- Ritonavir 50mg
Dosage Form:
Film coated tablet
Manufacturer:
Fournier Laboratories Ireland Limited, County Cork, Ireland
Component 2:
Active Ingredient:
Dasabuvir sodium monohydrate 270.26mg equivalent to Dasabuvir 250mg
Dosage Form:
Film coated tablet
Manufacturer:
AbbVie Ireland NL B.V., Sligo, Ireland
Component 3:
Active Ingredient:
Ribavirin 400mg
Dosage Form:
Film coated tablet
Manufacturer:
DSM Pharmaceuticals Inc, North Carolina, United States of America
Component 4:
Active Ingredient:
Ribavirin 600mg
Dosage Form:
Film coated tablet
Manufacturer:
DSM Pharmaceuticals Inc, North Carolina, United States of America
New Zealand Sponsor:
AbbVie Limited
Product:
VIMIZIM
Active Ingredient:
Elosulfase alfa 1mg/mL
Dosage Form:
Concentrate for infusion
New Zealand Sponsor:
Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Manufacturers:
- Vetter Pharma-Fertigung GmbH & Co KG, Ravensburg, Germany
- Vetter Pharma-Fertigung GmbH & Co KG, Langenargen, Germany
Dated this 14th day of August 2015.
CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).
2015-go4880
Consent to the Distribution of a New Medicine
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine which was referred to the Minister of Health under the provisions of section 24(5) of the Act and is set out in the Schedule hereto:
Schedule
Product:
Tobrex
Active Ingredient:
Tobramycin 0.3%w/w
Dosage Form:
Eye ointment
New Zealand Sponsor:
Pharmaco (NZ) Limited
Manufacturers:
- Alcon Laboratories Inc, Texas, United States of America
- SA Alcon Couvreur NV, Puurs, Belgium
- Alcon Cusi SA, Barcelona, Spain
Dated this 14th day of August 2015.
CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).
2015-go4881
Supplementary Integration Agreements
Pursuant to section 10 of the Private Schools Conditional Integration Act 1975, notice is given that supplementary integration agreements have been signed between the Minister of Education on behalf of Her Majesty The Queen, acting through the Group Manager, Schools and Student Support, Ministry of Education, pursuant to delegated authority, and the proprietors of the following schools:
Aquinas College, Tauranga (482)
107
Next Page →
β¨ LLM interpretation of page content
π₯
Registration of Viekira Pak-RBV
(continued from previous page)
π₯ Health & Social Welfare14 August 2015
Medicines, Registration, Ombitasvir, Paritaprevir, Ritonavir, Dasabuvir, Ribavirin, Film coated tablet, AbbVie
- CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health
π₯ Registration of VIMIZIM
π₯ Health & Social Welfare14 August 2015
Medicines, Registration, Elosulfase alfa, Concentrate for infusion, Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
- CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health
π₯ Consent to the Distribution of a New Medicine - Tobrex
π₯ Health & Social Welfare14 August 2015
Medicines, Distribution, Tobramycin, Eye ointment, Pharmaco (NZ) Limited
- CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health
π Supplementary Integration Agreements
π Education, Culture & Science14 August 2015
Education, Private Schools, Conditional Integration, Supplementary Integration Agreements, Aquinas College, Tauranga
- Group Manager, Schools and Student Support, Ministry of Education
NZ Gazette 2015, No 90